NEVVI Medicare utilization intelligence

← back

MARESCA, MICHAELM.D. NPI 1194893727 Clinician

Hematology-Oncology · POUGHKEEPSIE, NY

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 29 years since medical school (class of 1997, self-reported to CMS)
Location POUGHKEEPSIE, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 87 codes billed · 81,163 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
2025–2026
HUDSON VALLEY HEMATOLOGY ONCOLOGY ASSOCIATES, RLLP
2019–2024

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2009-12

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
88185 Flow cytometry technique for dna or cell analysis, each additional marker
J1100 Injection, dexamethasone sodium phosphate, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
83615 Lactate dehydrogenase (enzyme) level
83735 Magnesium level
84100 Phosphate level
36415 Insertion of needle into vein for collection of blood sample
84550 Uric acid level, blood
82784 Gammaglobulin (immune system protein) measurement
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
82728 Ferritin (blood protein) level
J2469 Injection, palonosetron hcl, 25 mcg
96372 Injection of drug or substance under skin or into muscle
82607 Cyanocobalamin (vitamin b-12) level
J2405 Injection, ondansetron hydrochloride, per 1 mg
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
82746 Folic acid level, serum
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
83521 Measurement of immunoglobulin light chains
83540 Iron level
83550 Iron binding capacity
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
82977 Glutamyltransferase (liver enzyme) level
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
83010 Haptoglobin (serum protein) level
86334 Immunologic analysis technique on serum (immunofixation)
84165 Protein measurement, serum
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
82248 Bilirubin level, direct
82378 Carcinoembryonic antigen (cea) protein level
85044 Red blood count, manual test
83883 Nephelometry, test method using light
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
82232 Beta-2 microglobulin (protein) level
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
84466 Transferrin (iron binding protein) level
J3475 Injection, magnesium sulfate, per 500 mg
84443 Blood test, thyroid stimulating hormone (tsh)
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
85610 Blood test, clotting time
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96375 Injection of additional new drug or substance into vein
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
82668 Erythropoietin (protein) level
88184 Flow cytometry technique for dna or cell analysis, first marker
J1200 Injection, diphenhydramine hcl, up to 50 mg
86141 Measurement c-reactive protein for detection of infection or inflammation, high sensitivity
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
84153 Psa (prostate specific antigen) measurement, total
86140 Measurement c-reactive protein for detection of infection or inflammation
96417 Administration of additional new drug or substance into vein, 1 hour or less
84439 Thyroxine (thyroid chemical), free
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
86235 Measurement of antibody for assessment of autoimmune disorder, any method
82306 Vitamin d-3 level
80048 Blood test, basic group of blood chemicals (calcium, total)
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96415 Administration of chemotherapy into vein, each additional hour
84480 Thyroid hormone, t3 measurement, total
86146 Beta 2 glycoprotein 1 antibody (autoantibody) measurement
86147 Cardiolipin antibody (tissue antibody) measurement
99195 Drawing of blood for a medical problem
86376 Microsomal antibodies (autoantibody) measurement
86800 Thyroglobulin (thyroid protein) antibody measurement
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
96523 Irrigation of implanted venous access drug delivery device
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
82533 Cortisol (hormone) measurement, total
86431 Rheumatoid factor level
82785 Ige (immune system protein) level
96361 Infusion into a vein for hydration, each additional hour
96374 Injection of drug or substance into vein
99442 Telephone medical discussion with physician, 11-20 minutes
86038 Screening test for autoimmune disorder
84403 Testosterone (hormone) level, total
86225 Measurement of dna antibody, native or double stranded
80074 Acute hepatitis panel

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.